This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Kornepati Ramakrishna: Innovator in Pharmaceutical Compositions
Introduction
Kornepati Ramakrishna, an accomplished inventor based in Cary, NC, holds a significant patent in the field of pharmaceutical compositions. His innovative work focuses on creating methods to produce low impurity concentrations, contributing to advancements in drug formulation.
Latest Patents
Kornepati Ramakrishna's most notable patent is titled "Pharmaceutical compositions and methods for producing low impurity concentrations of the same." This patent describes a composition featuring clevidipine as the active ingredient. Remarkably, the composition ensures that the impurity H168/79 does not exceed 1.5%, or maintains a ratio of clevidipine to H168/79 of 60 to 1 or greater. This innovation is crucial for improving the safety and efficacy of pharmaceutical products.
Career Highlights
Kornepati Ramakrishna is currently associated with Chiesi Farmaceutici, a prominent company in the pharmaceutical sector. His work at Chiesi highlights his commitment to enhancing drug formulations and ensuring patient safety through innovative solutions.
Collaborations
Throughout his career, Kornepati has collaborated with esteemed colleagues such as Rajeshwar Motheram and Gopal Krishna. These collaborations have been instrumental in fostering an environment of innovation and excellence within the pharmaceutical industry.
Conclusion
Kornepati Ramakrishna's contributions to the field of pharmaceuticals demonstrate his dedication to innovation and the development of safe drug formulations. With his patent focusing on low impurity concentrations, Ramakrishna continues to pave the way for future advancements in the industry. His work not only benefits consumers but also enhances the standards of pharmaceutical care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
